Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

COVID 2025’ is trending across the US as Americans react to a major shift in COVID-19 vaccine policy by the Food and Drug Administration (FDA).This fall, the FDA plans to limit vaccine access to ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ending a politically and economically inconvenient crisis. Over time, ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...